| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70756-051-11 | 70756-051 | HUMAN PRESCRIPTION DRUG | Famotidine | Famotidine | TABLET | ORAL | 20231019 | N/A | ANDA | ANDA075302 | Lifestar Pharma LLC | FAMOTIDINE | 20 mg/1 | 100 TABLET in 1 BOTTLE (70756-051-11) |
| 70756-051-12 | 70756-051 | HUMAN PRESCRIPTION DRUG | Famotidine | Famotidine | TABLET | ORAL | 20231019 | N/A | ANDA | ANDA075302 | Lifestar Pharma LLC | FAMOTIDINE | 20 mg/1 | 1000 TABLET in 1 BOTTLE (70756-051-12) |
| 70756-052-11 | 70756-052 | HUMAN PRESCRIPTION DRUG | Famotidine | Famotidine | TABLET | ORAL | 20231019 | N/A | ANDA | ANDA075302 | Lifestar Pharma LLC | FAMOTIDINE | 40 mg/1 | 100 TABLET in 1 BOTTLE (70756-052-11) |
| 70756-052-12 | 70756-052 | HUMAN PRESCRIPTION DRUG | Famotidine | Famotidine | TABLET | ORAL | 20231019 | N/A | ANDA | ANDA075302 | Lifestar Pharma LLC | FAMOTIDINE | 40 mg/1 | 1000 TABLET in 1 BOTTLE (70756-052-12) |
| 67296-2133-3 | 67296-2133 | HUMAN PRESCRIPTION DRUG | Famotidine | Famotidine | TABLET | ORAL | 20231019 | N/A | ANDA | ANDA075302 | Redpharm Drug | FAMOTIDINE | 20 mg/1 | 30 TABLET in 1 BOTTLE (67296-2133-3) |
| 67046-1427-3 | 67046-1427 | HUMAN PRESCRIPTION DRUG | Famotidine | Famotidine | TABLET | ORAL | 20241105 | N/A | ANDA | ANDA075302 | Coupler LLC | FAMOTIDINE | 20 mg/1 | 30 TABLET in 1 BLISTER PACK (67046-1427-3) |